According to FutureWise analysis the market for Mitochondrial-based Therapeutics in 2023 was US$ 0.4 billion, and is expected to reach US$ 0.74 billion by 2031 at a CAGR of 8.02%. Mitochondrial-based therapeutics offer promising treatment options for a range of indications, including mitochondrial myopathy, Leigh syndrome, mitochondrial DNA depletion syndrome, and more. Targeted therapies, gene...